Mounjaro 7.5 MG/0.5 ML pen 0.5ML

Ended Awarded Last action

Contract number
SPE2DR26FN0J7
Awardee
Awarding agency
Obligated
$16,217

Award facts

Contract value 100% obligated
$16,216.90 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency awarded a $16,216.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injectables on January 16, 2026, with completion expected by January 20, 2026. The award, which utilized no set-aside designation, represents a competitively awarded purchase of this diabetes medication to support federal healthcare needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with parent company Cencora, Inc. providing organizational oversight. This delivery order is executed under a larger Indefinite Delivery Contract vehicle with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which authorizes the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to military healthcare systems.

The DLA Medical Supply Chain utilizes this indefinite delivery contract as a critical procurement mechanism for supporting Defense Health Agency operations, the U.S. Coast Guard, and other federal healthcare systems with essential pharmaceutical commodities across multiple therapeutic domains. AmerisourceBergen's federal contract portfolio demonstrates substantial capability in fulfilling specialized pharmaceutical requirements, with transaction values ranging from under $100 to orders exceeding $45,000. The firm fixed-price delivery order structure and competitive award status reflect the company's established performance record in meeting federal medical procurement standards and timely supply chain delivery requirements for military treatment facilities and veteran healthcare programs.

Quick answers

Who was awarded contract SPE2DR26FN0J7?

SPE2DR26FN0J7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.

How much is contract SPE2DR26FN0J7 worth?

The government has obligated $16,217 on SPE2DR26FN0J7.

Is contract SPE2DR26FN0J7 an order under another contract?

Yes. SPE2DR26FN0J7 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.

Was contract SPE2DR26FN0J7 competed?

The extent of competition for SPE2DR26FN0J7 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award